Pure Global AI
NCT05810571Not yet recruiting

Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical Study

Comparison of Erector Spina and Quadratus Lumborum in Open Nephrectomy
Kocaeli UniversityClinicalTrials.govprocedure
Verified
Study focus
Disease/Condition
Renal Cell Carcinoma
Drug/Device/Intervention
preoperative remifentanil consumption
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Kocaeli University
Location
Kocaeli,Kocaeli, Turkey
Timeline & enrollment
Phase
N/A
Start date
Mar 01, 2023
End date
Apr 03, 2024
Enrollment
60 participants
Primary outcome

postoperative morphine consumption

Summary

patients who will undergo elective open nephrectomy will be divided into three groups; the
 control (PCA), the erector spina plane block, and the quadratus lumborum block. After
 standard anesthesia induction and monitorization then Bispectral index monitoring will be
 applied to all patients. Anesthesia will be maintained using sevoflurane in a mixture of
 oxygen and air. Continuous remifentanil infusion will be used for analgesia. Then patient's
 numeric rating scales and morphine pca consumptions will be recorded for one day.

ICD-10 classifications
Malignant neoplasm of kidney, except renal pelvisMalignant neoplasm of renal pelvisSecondary malignant neoplasm of kidney and renal pelvisBenign neoplasm: KidneyBenign neoplasm: Renal pelvis
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05810571
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05810571 through Pure Global AI's free database. This phase not specified trial is sponsored by Kocaeli University and is currently Not yet recruiting. The study focuses on Renal Cell Carcinoma. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.